[
    [
        {
            "time": "2023-10-05",
            "original_text": "A Diabetes Treatment Revolution Could Bolster These Medtech Firms",
            "features": {
                "keywords": [
                    "Diabetes",
                    "Treatment",
                    "Revolution",
                    "Bolster",
                    "Medtech"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "A Diabetes Treatment Revolution Could Bolster These Medtech Firms",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "An Abbott Labs Analyst's 5 Reasons To Own The Stock: 'Near-Perfect For This Environment'",
            "features": {
                "keywords": [
                    "Abbott",
                    "Labs",
                    "Analyst",
                    "Reasons",
                    "Own",
                    "Stock",
                    "Near-Perfect",
                    "Environment"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "An Abbott Labs Analyst's 5 Reasons To Own The Stock: 'Near-Perfect For This Environment'",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]